The round was led by IrishAngels, KOFA Healthcare and Jaffray Woodriff (executed by his family office, Felton Group, LLC), with participation from both new and existing individual investors.
The company intends to use the proceeds for global commercialization activities for its monitor and to forge OEM partnerships to integrate their wireless CNIBP and Vital Signs technology with other patient monitoring platforms.
Led by President and CEO Jeff Pompeo, CareTaker Medical provides FDA-Cleared, Wireless CareTaker® Continuous “Beat by Beat” Non-Invasive Blood Pressure (“CNIBP”) and Vital Signs monitor which enables untethered, continuous patient monitoring with a simple finger cuff.
The wearable CareTaker4® patient monitor enables uninterrupted wire-free and electrode-free real-time vital signs monitoring throughout the full continuum of care, from clinic and hospital, to patient transport, and home monitoring after discharge. Using a low-pressure finger cuff, CareTaker’s patented Pulse Decomposition Analysis technology non-invasively measures continuous Beat-by-Beat blood pressure, Heart Rate, and Respiration Rate for remote display on the CareTaker Tablet App and other Remote Data Displays.
In Q1, the company announced integration with the Philips IntelliVue family of patient monitors and now is testing additional hemodynamic parameters using their patented Pulse Decomposition Analysis technology and low-pressure, disposable Finger Cuff, which will be added to the CareTaker monitor next year.
FinSMEs
17/05/2018